Literature DB >> 29463545

Detection of TR34/L98H CYP51A Mutation through Passive Surveillance for Azole-Resistant Aspergillus fumigatus in the United States from 2015 to 2017.

Elizabeth L Berkow1, Natalie S Nunnally1, Alex Bandea1, Randall Kuykendall1, Karlyn Beer1, Shawn R Lockhart2.   

Abstract

The emergence of azole-resistant Aspergillus fumigatus has become a clinical problem in many parts of the world. Several amino acid mutations in the azole target protein Cyp51Ap contribute to this resistance, with the most concerning being the environmentally derived TR34/L98H and TR46/Y121F/T289A mutations. Here, we performed passive surveillance to assess a sample of the A. fumigatus population in the United States for the presence of these mutations. We found 1.4% of those isolates to exhibit elevated MIC via broth microdilution, and five of those isolates harbored the TR34/L98H mutation. This is a work of the U.S. Government and is not subject to copyright protection in the United States. Foreign copyrights may apply.

Entities:  

Keywords:  Aspergillus fumigatus; CYP51A mutation; TR34/L98H; TR46/Y121F/T289A; azole resistance

Mesh:

Substances:

Year:  2018        PMID: 29463545      PMCID: PMC5923109          DOI: 10.1128/AAC.02240-17

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

1.  Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.

Authors:  Thomas J Walsh; Elias J Anaissie; David W Denning; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; Brahm H Segal; William J Steinbach; David A Stevens; Jo-Anne van Burik; John R Wingard; Thomas F Patterson
Journal:  Clin Infect Dis       Date:  2008-02-01       Impact factor: 9.079

2.  Azole resistance in Aspergillus fumigatus isolates from the ARTEMIS global surveillance study is primarily due to the TR/L98H mutation in the cyp51A gene.

Authors:  Shawn R Lockhart; João P Frade; Kizee A Etienne; Michael A Pfaller; Daniel J Diekema; S Arunmozhi Balajee
Journal:  Antimicrob Agents Chemother       Date:  2011-06-20       Impact factor: 5.191

3.  Multi-triazole-resistant Aspergillus fumigatus infections in Australia.

Authors:  Sarah E Kidd; Emma Goeman; Jacques F Meis; Monica A Slavin; Paul E Verweij
Journal:  Mycoses       Date:  2015-04-17       Impact factor: 4.377

4.  Molecular Characterization of a Voriconazole-Resistant, Posaconazole-Susceptible Aspergillus fumigatus Isolate in a Lung Transplant Recipient in the United States.

Authors:  Jose A Vazquez; Elias K Manavathu
Journal:  Antimicrob Agents Chemother       Date:  2015-11-16       Impact factor: 5.191

5.  Composite survival index to compare virulence changes in azole-resistant Aspergillus fumigatus clinical isolates.

Authors:  Eleftheria Mavridou; Joseph Meletiadis; Pavol Jancura; Saiden Abbas; Maiken C Arendrup; Willem J G Melchers; Tom Heskes; Johan W Mouton; Paul E Verweij
Journal:  PLoS One       Date:  2013-08-26       Impact factor: 3.240

6.  Passive surveillance for azole-resistant Aspergillus fumigatus, United States, 2011-2013.

Authors:  Cau D Pham; Errol Reiss; Ferry Hagen; Jacques F Meis; Shawn R Lockhart
Journal:  Emerg Infect Dis       Date:  2014-09       Impact factor: 6.883

Review 7.  Multiple mechanisms contribute to the development of clinically significant azole resistance in Aspergillus fumigatus.

Authors:  W S Moye-Rowley
Journal:  Front Microbiol       Date:  2015-01-10       Impact factor: 5.640

8.  Multiple Fungicide-Driven Alterations in Azole-Resistant Aspergillus fumigatus, Colombia, 2015.

Authors:  Patrice Le Pape; Rose-Anne Lavergne; Florent Morio; Carlos Alvarez-Moreno
Journal:  Emerg Infect Dis       Date:  2016-01       Impact factor: 6.883

9.  Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure.

Authors:  Susan J Howard; Dasa Cerar; Michael J Anderson; Ahmed Albarrag; Matthew C Fisher; Alessandro C Pasqualotto; Michel Laverdiere; Maiken C Arendrup; David S Perlin; David W Denning
Journal:  Emerg Infect Dis       Date:  2009-07       Impact factor: 6.883

10.  Azole-resistant Aspergillus fumigatus, Iran.

Authors:  Seyedmojtaba Seyedmousavi; Seyed Jamal Hashemi; Ensieh Zibafar; Jan Zoll; Mohammad T Hedayati; Johan W Mouton; Willem J G Melchers; Paul E Verweij
Journal:  Emerg Infect Dis       Date:  2013-05       Impact factor: 6.883

View more
  14 in total

Review 1.  Aspergillus fumigatus and aspergillosis: From basics to clinics.

Authors:  A Arastehfar; A Carvalho; J Houbraken; L Lombardi; R Garcia-Rubio; J D Jenks; O Rivero-Menendez; R Aljohani; I D Jacobsen; J Berman; N Osherov; M T Hedayati; M Ilkit; D James-Armstrong; T Gabaldón; J Meletiadis; M Kostrzewa; W Pan; C Lass-Flörl; D S Perlin; M Hoenigl
Journal:  Stud Mycol       Date:  2021-05-10       Impact factor: 16.097

2.  Clinical Characteristics, Health Care Utilization, and Outcomes Among Patients in a Pilot Surveillance System for Invasive Mold Disease-Georgia, United States, 2017-2019.

Authors:  Jeremy A W Gold; Andrew Revis; Stepy Thomas; Lewis Perry; Rebekah A Blakney; Taylor Chambers; Meghan L Bentz; Elizabeth L Berkow; Shawn R Lockhart; Colleen Lysen; Natalie S Nunnally; Alexander Jordan; Hilary C Kelly; Alejandro J Montero; Monica M Farley; Nora T Oliver; Stephanie M Pouch; Andrew S Webster; Brendan R Jackson; Karlyn D Beer
Journal:  Open Forum Infect Dis       Date:  2022-04-21       Impact factor: 4.423

3.  Breakthrough Invasive Mold Infections in the Hematology Patient: Current Concepts and Future Directions.

Authors:  Michail S Lionakis; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2018-10-30       Impact factor: 9.079

4.  Recognition of Diagnostic Gaps for Laboratory Diagnosis of Fungal Diseases: Expert Opinion from the Fungal Diagnostics Laboratories Consortium (FDLC).

Authors:  Sean X Zhang; N Esther Babady; Kimberly E Hanson; Amanda T Harrington; Paige M K Larkin; Sixto M Leal; Paul M Luethy; Isabella W Martin; Preeti Pancholi; Gary W Procop; Stefan Riedel; Seyedmojtaba Seyedmousavi; Kaede V Sullivan; Thomas J Walsh; Shawn R Lockhart
Journal:  J Clin Microbiol       Date:  2021-06-18       Impact factor: 5.948

5.  Evidence for the agricultural origin of resistance to multiple antimicrobials in Aspergillus fumigatus, a fungal pathogen of humans.

Authors:  S Earl Kang; Leilani G Sumabat; Tina Melie; Brandon Mangum; Michelle Momany; Marin T Brewer
Journal:  G3 (Bethesda)       Date:  2022-02-04       Impact factor: 3.542

6.  Multidrug-Resistant Aspergillus fumigatus Carrying Mutations Linked to Environmental Fungicide Exposure - Three States, 2010-2017.

Authors:  Karlyn D Beer; Eileen C Farnon; Seema Jain; Carol Jamerson; Sarah Lineberger; Jeffrey Miller; Elizabeth L Berkow; Shawn R Lockhart; Tom Chiller; Brendan R Jackson
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-09-28       Impact factor: 17.586

Review 7.  Emerging Fungal Infections: New Patients, New Patterns, and New Pathogens.

Authors:  Daniel Z P Friedman; Ilan S Schwartz
Journal:  J Fungi (Basel)       Date:  2019-07-20

8.  The Emergence of Rare Clinical Aspergillus Species in Qatar: Molecular Characterization and Antifungal Susceptibility Profiles.

Authors:  Husam Salah; Michaela Lackner; Jos Houbraken; Bart Theelen; Cornelia Lass-Flörl; Teun Boekhout; Muna Almaslamani; Saad J Taj-Aldeen
Journal:  Front Microbiol       Date:  2019-07-30       Impact factor: 5.640

9.  In Vitro Activity of Novel Antifungal Olorofim against Filamentous Fungi and Comparison to Eight Other Antifungal Agents.

Authors:  Ourania Georgacopoulos; Natalie S Nunnally; Eric M Ransom; Derek Law; Mike Birch; Shawn R Lockhart; Elizabeth L Berkow
Journal:  J Fungi (Basel)       Date:  2021-05-12

10.  Surveillance for Azole-Resistant Aspergillus fumigatus in a Centralized Diagnostic Mycology Service, London, United Kingdom, 1998-2017.

Authors:  Alireza Abdolrasouli; Michael A Petrou; Hyun Park; Johanna L Rhodes; Timothy M Rawson; Luke S P Moore; Hugo Donaldson; Alison H Holmes; Matthew C Fisher; Darius Armstrong-James
Journal:  Front Microbiol       Date:  2018-09-20       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.